Tin tức & Cập nhật

Ngày Thế giới về Não 22/07/2024

Bảo vệ sức khỏe não bộ - Bảo vệ tương lai

Não bộ là cơ quan quan trọng chi phối mọi hoạt động của cơ thể

Nipocalimab + SoC improves MG-ADL scores in adults with myasthenia gravis

Adding nipocalimab to standard-of-care (SoC) treatment significantly improves Myasthenia Gravis-Activities of Daily Living (MG-ADL) scores in patients with generalized MG (gMG), according to the pivotal phase III Vivacity-MG3 study presented at EAN 2024.

Prenatal air pollution exposure tied to increased cerebral palsy risk

Prenatal exposure to fine particulate matter appears to put newborns at risk of cerebral palsy, as shown in a study.

Omaveloxolone slows neurological progression in earlier-onset Friedreich’s ataxia

The treatment effect of omaveloxolone in halting progression, based on change in mFARS score, is particularly pronounced in individuals with Friedreich's ataxia who had disease onset at ≤15 years of age, suggests a post hoc subgroup analysis of MOXIe Part 2 presented at EAN 2024.

Benralizumab facilitates complete withdrawal of OGCs more than mepolizumab in EGPA

Benralizumab offers more sustained and earlier elimination of oral GCs vs mepolizumab in patients with relapsing or refractory EGPA, suggests a post hoc analysis of the MANDARA study presented at EULAR 2024

JAK inhibitors for autoimmune disease may confer protection against AMD

The use of Janus kinase (JAK) inhibitors in the treatment of major autoimmune diseases appears to reduce the risk of age-related macular degeneration (AMD) for people above 40 years of age, according to a study.